Ibere Pharmaceuticals IBER
We take great care to ensure that the data presented and summarized in this overview for IBERE PHARMACEUTICALS is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding IBER
View allLatest Institutional Activity in IBER
Top Purchases
Top Sells
About IBER
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
Insider Transactions at IBER
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 02
2021
|
Louis J. Vollmer Director |
BUY
Open market or private purchase
|
Direct |
10,000
+22.22%
|
$100,000
$10.0 P/Share
|